SEC Form 4 · accession 0001214659-19-000560
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron Durrant
Officer — Chief Executive Officer · Director
Period of report
Jan 25, 2019
Accepted (ET)
Jan 28, 2019 · 8:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.84 | Jan 25, 2019 | A | 142,857 | A | Jan 25, 2019 | Jan 24, 2029 | Common Stock | 142,857 | 142,857 | D |
Explanation of responses
- F1These stock options were granted in lieu of a portion of the cash bonus payable to Dr. Durrant in respect of his services as Chief Executive Officer in 2018.